A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma
Open Access
- 1 December 1993
- Vol. 72 (11) , 3196-3201
- https://doi.org/10.1002/1097-0142(19931201)72:11<3196::aid-cncr2820721111>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.Journal of Clinical Oncology, 1990
- A phase II trial of tamoxifen in hepatocellular carcinomaCancer, 1990
- Recombinant α2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trialBritish Journal of Cancer, 1989
- Hepatocellular CarcinomaAnnals of Internal Medicine, 1988
- Clinical trials in primary hepatocellular carcinoma: current status and future directionsCancer Treatment Reviews, 1988
- Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: A pilot studyBritish Journal of Cancer, 1985
- Mitozantrone as single agent therapy in hepatocellular carcinomaJournal of Hepatology, 1985
- The Combined Effect of Interferon-β and Cytostatic Drugs on Human Tumor Cell Lines In VitroJournal of Interferon Research, 1985
- Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic studyCancer, 1984
- Clinical and Immunological Study of Beta Interferon by Intramuscular Route in Patients with Metastatic Breast CancerJournal of Interferon Research, 1982